E-LIB Suche - Ergebnisse für: Gerald S Falchook

1

Postmalaria Neurological Syndrome after Treatment of Plasmo..:

Gerald S. Falchook ; Clinton M. Malone ; Scott Upton.
Clinical Infectious Diseases. 37 (2003) 2 - p. 317 ff. , 2003

Link: https://www.jstor.org/st..

2

A phase 2 study of AZD4635 in combination with durvalumab o..:

Falchook, Gerald S. ; Reeves, James ; Gandhi, Sunil...
Cancer Immunology, Immunotherapy. 73 (2024) 4 - p. , 2024

Link: https://doi.org/10.1007/..

3

Sotorasib with panitumumab in chemotherapy-refractory KRASG..:

Kuboki, Yasutoshi ; Fakih, Marwan ; Strickler, John...
Nature Medicine. 30 (2024) 1 - p. 265-270 , 2024

Link: https://doi.org/10.1038/..

4

T cell Immunoglobulin and Mucin Domain Containing Protein 3..:

Duong, Benjamin ; Banskota, Pratyush ; Falchook, Gerald S.
Journal of Immunotherapy and Precision Oncology. 7 (2024) 2 - p. 89-96 , 2024

Link: https://doi.org/10.36401..

5

B7-H3 Inhibitors in Oncology Clinical Trials: A Review:

Feustel, Kavanya ; Martin, Jared ; Falchook, Gerald S.
Journal of Immunotherapy and Precision Oncology. 7 (2024) 1 - p. 53-66 , 2024

Link: https://doi.org/10.36401..

6

A dose escalation/expansion study evaluating dose, safety, ..:

Dasari, Arvind ; Hamilton, Erika P. ; Falchook, Gerald S....
Investigational New Drugs. 41 (2023) 3 - p. 421-430 , 2023

Link: https://doi.org/10.1007/..

7

A phase 1/2a safety, pharmacokinetics, and efficacy study o..:

Janku, Filip ; Javle, Milind M. ; Sen, Shiraj...
Cancer. 129 (2023) 10 - p. 1537-1546 , 2023

Link: https://doi.org/10.1002/..

8

Long-Term Benefit of Sotorasib in Patients With KRAS G12C–M..:

Dy, Grace K ; Govindan, Ramaswamy ; Velcheti, Vamsidhar...
Future Oncology. 20 (2023) 3 - p. 113-120 , 2023

Link: https://doi.org/10.2217/..

9

A phase Ib study of adavosertib, a selective Wee1 inhibitor..:

Falchook, Gerald S ; Sachdev, Jasgit ; Imedio, Esteban Rodrigo...
Investigational New Drugs. 41 (2023) 3 - p. 493-502 , 2023

Link: https://doi.org/10.1007/..

10

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist ..:

Yap, Timothy A. ; Gainor, Justin F. ; Callahan, Margaret K....
Clinical Cancer Research. 28 (2022) 17 - p. 3695-3708 , 2022

Link: https://doi.org/10.1158/..

11

Phase 1/2 study of epacadostat in combination with durvalum..:

Naing, Aung ; Algazi, Alain P. ; Falchook, Gerald S....
Cancer. 129 (2022) 1 - p. 71-81 , 2022

Link: https://doi.org/10.1002/..

12

Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors in ..:

Feustel, Kavanya ; Falchook, Gerald S.
Journal of Immunotherapy and Precision Oncology. 5 (2022) 3 - p. 58-67 , 2022

Link: https://doi.org/10.36401..

13

Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Ad..:

Lim, Emerson A. ; Bendell, Johanna C. ; Falchook, Gerald S....
Clinical Cancer Research. 28 (2022) 22 - p. 4871-4884 , 2022

Link: https://doi.org/10.1158/..

14

Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of..:

Saleh, Mansoor N. ; Patel, Manish R. ; Bauer, Todd M....
Clinical Cancer Research. 28 (2022) 2 - p. 429-429 , 2022

Link: https://doi.org/10.1158/..

15

Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MD..:

Saleh, Mansoor N. ; Patel, Manish R. ; Bauer, Todd M....
Clinical Cancer Research. 27 (2021) 19 - p. 5236-5247 , 2021

Link: https://doi.org/10.1158/..